SBUX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Starbucks Corp (SBUX) does not present a compelling buy opportunity for a beginner, long-term investor at this time. While the company has positive growth potential and operational improvements underway, the current valuation appears stretched, and financial performance in the latest quarter shows significant declines in net income and EPS. Additionally, mixed analyst ratings and a lack of strong trading signals suggest waiting for clearer entry points or improved financial visibility.
The technical indicators show a mixed picture. The MACD is positive and contracting, indicating a potential bullish trend. The RSI is neutral at 73.772, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the pre-market price is slightly down (-0.04%), and the stock is trading near its resistance level of 98.781, suggesting limited upside in the short term.
Starbucks' turnaround strategy, including AI-driven innovation and global expansion, is expected to drive long-term shareholder value.
Analysts see potential for significant profit growth by fiscal 2028, with EPS projected to reach $3.35-$4.
Bullish moving averages and a strong pivot support level at 94.571.
Financial performance in Q1 2026 shows a significant decline in net income (-62.44% YoY) and EPS (-62.32% YoY).
Analysts have mixed ratings, with some citing high valuation and execution risks.
Competitive pressures from rivals like McDonald's and a challenging coffee market landscape.
In Q1 2026, Starbucks reported a 5.50% YoY increase in revenue to $9.92 billion. However, net income dropped significantly by -62.44% YoY to $293.3 million, and EPS fell by -62.32% YoY to $0.26. Gross margin also declined to 17.03%, down -15.48% YoY, indicating profitability challenges.
Analyst ratings are mixed. Tigress Financial resumed coverage with a Buy rating and a $122 price target, citing operational improvements and global expansion. However, other firms like Jefferies and BNP Paribas have downgraded the stock, citing high valuation and execution risks. Recent price targets range from $84 to $122, reflecting divided sentiment.
